3^rd Annual Summit on Diabetes and Endocrinology September 14-15, 2023 Bangkok, Thailand

Track 1: Diabetes types and Complications

Diabetes mellitus type 1 (otherwise called type 1 diabetes) is a type of diabetes mellitus that outcomes from the immune system annihilation of the insulin-delivering beta cells in the pancreas. The ensuing absence of hypoglycaemic agent prompts expanded  aldohexose within the blood and pee. The established manifestations are regular pee, expanded thirst, expanded yearning, and weight reduction. Type 2 diabetes may be a long-term metabolic turmoil that's pictured by high aldohexose, insulin resistance, and relative absence of insulin. Basic aspect effects incorporate expanded thirst, incessant pee, and unexplained weight reduction. Indications could likewise incorporate swollen desire, feeling tired, and bruises that don't recuperate. Regularly indications go ahead gradually.

Diabetes Conferences | Upcoming Diabetes Conferences | Obesity Summit | Endocrinology Conferences | Metabolism Events | Diabetes Meetings | Neuroendocrinology | Gestational Diabetes | Genetic of Obesity | Paediatric Endocrinology | Thyroid Disorders | Diabetes and Cancer

Track 2: Insulin Resistance and Insulin therapy

Insulin is a peptide hormone produced by the cells of the pancreatic islets of Langerhans that regulates blood glucose levels by aiding cellular glucose uptake, regulating carbohydrate, lipid, and protein metabolism, and encouraging cell division and proliferation through its mitogenic activities. Insulin resistance and its consequences are becoming more prominent as obesity and diabetes reach epidemic proportions in the developed world. Insulin resistance is described as a biological response that is diminished by a normal or elevated insulin level; traditionally, this refers to impaired sensitivity to insulin-mediated glucose disposal. Insulin resistance syndrome is a collection of anomalies and physical consequences that are more likely in people who are insulin resistant.

Diabetes Conferences | Upcoming Diabetes Conferences | Obesity Summit | Endocrinology Conferences | Metabolism Events | Diabetes Meetings | Neuroendocrinology | Gestational Diabetes | Genetic of Obesity | Paediatric Endocrinology | Thyroid Disorders | Diabetes and Cancer

Track 3: Pediatric Diabetes and Reproductive Endocrinology

The kinds of diabetes mellitus (diabetes) seen in children are similar to those seen in adults, psychosocial issues might complicate treatment. The most frequent type of diabetes in children is type 1, which accounts for two-thirds of new cases in children of all ethnic groups. Reproductive Endocrinology is the detailed science of the feminine hormone system from puberty through menopause with the functions of the pituitary, infertility, and ovaries. Reproductive Endocrinology covers different areas like hormonal control of implantation and fertility and early embryonic development, early embryonic development, embryo-uterus interaction, gametogenesis, fertilization, reproductive development, pregnancy, uterine biology, endocrinology of reproduction, control of reproduction, reproductive immunology

Diabetes Conferences | Upcoming Diabetes Conferences | Obesity Summit | Endocrinology Conferences | Metabolism Events | Diabetes Meetings | Neuroendocrinology | Gestational Diabetes | Genetic of Obesity | Paediatric Endocrinology | Thyroid Disorders | Diabetes and Cancer

Track 4: Obesity

Obesity is usually caused by an underlying disease of increased bodily fat accumulation. It has a significant detrimental effect on health, particularly by increasing the risk of other chronic conditions including heart disease and diabetes. Obesity is characterized as having a BMI of more than 30 kg/m2. Obesity is one of the most common diseases in developed countries, and its prevalence is continuously increasing. Obese people are more likely to acquire type 2 diabetes, also known as insulin-resistant diabetes or adult-onset diabetes. This is a condition in which your blood glucose level remains high for an extended period of time. Obese people are up to 80 times more likely than non-obese persons to develop type 2 diabetes, according to research.

Diabetes Conferences | Upcoming Diabetes Conferences | Obesity Summit | Endocrinology Conferences | Metabolism Events | Diabetes Meetings | Neuroendocrinology | Gestational Diabetes | Genetic of Obesity | Paediatric Endocrinology | Thyroid Disorders | Diabetes and Cancer

Track 5: Thyroid Disorders

Since the thyroid gland plays a valuable function inside the law of metabolism, ordinary thyroid feature may have a first-rate impact at the manipulate of diabetes. In addition, untreated thyroid disorder can growth the risk of sure diabetic complications and might worsen many diabetes signs and symptoms. Like kind 1 diabetes, some kinds of thyroid sickness are autoimmune problems, attacks in opposition to a few a part of the body with the aid of one's personal immune system. A person with one autoimmune sickness is more likely to get every other. In kind 1, the immune machine assaults the cells inside the pancreas that make insulin. In some varieties of thyroid disorder, the immune device assaults the cells of the thyroid. The link with kind 2 diabetes is less clean, however a few experts think it can have to do with growing older. Like kind 2, thyroid ailment is more common among older adults. 

Diabetes Conferences | Upcoming Diabetes Conferences | Obesity Summit | Endocrinology Conferences | Metabolism Events | Diabetes Meetings | Neuroendocrinology | Gestational Diabetes | Genetic of Obesity | Paediatric Endocrinology | Thyroid Disorders | Diabetes and Cancer

Track 6: Stem Cell treatment in Diabetes

In islet cell transplants to cure type 1 diabetes by using Stem cells, replacement of stem cells should be more than just an instance of swapping insulin-delivering cells from a healthy pancreas with those annihilated by diabetes during a diabetic patient. it's conceivable to treat Type 1 diabetes by transplanting confined islet cells, containing beta cells or maybe a whole pancreas into the patient from a contributor. Transplants can empower the body to recover control of glucose levels so administrating insulin isn't again required. Pancreatic islets, additionally called islets of Langerhans, are modest groups of cells scattered during the pancreas. Pancreatic islets contain a couple of sorts of cells, including beta cells that make the hormone insulin. Insulin enables cells during the body to retain glucose from the circulation system and utilize it for vitality.

Diabetes Conferences | Upcoming Diabetes Conferences | Obesity Summit | Endocrinology Conferences | Metabolism Events | Diabetes Meetings | Neuroendocrinology | Gestational Diabetes | Genetic of Obesity | Paediatric Endocrinology | Thyroid Disorders | Diabetes and Cancer

Track 7: Diabetes Research and Case Reports

Diabetes is a chronic metabolic condition that arises when the human body is unable to create enough insulin or when the insulin produced does not reach the cells. Frequent urination, increased thirst, and hunger are all indicators of high blood sugar. A clinical case report, often known as a case study, is a sort of academic publication in which medical practitioners present exceptional or previously undocumented patient cases. Writing a clinical case report requires obtaining patient consent and ensuring patient privacy. The earliest form of medical communication was clinical case reports. A case report, also known as a case study, is a way of distributing new knowledge gained from clinical practice.

Diabetes Conferences | Upcoming Diabetes Conferences | Obesity Summit | Endocrinology Conferences | Metabolism Events | Diabetes Meetings | Neuroendocrinology | Gestational Diabetes | Genetic of Obesity | Paediatric Endocrinology | Thyroid Disorders | Diabetes and Cancer

Track 8: Blood Glucose Dynamics and Monitoring

The determination of blood glucose levels is vital in the diagnosis and management of diabetes. Although individuals with diabetes have a great number of historical glucose measurements, there have been few data sets that have been recorded continuously or sampled frequently enough to reveal intrinsic blood glucose dynamics, or the change in blood glucose with time. There is even less data from people who do not have diabetes that could be utilized as a therapeutic target. As a result, blood sugar dynamics were rarely used in the diagnosis and treatment of diabetes. Although current blood sugar monitoring is primarily based on discrete measurements, future monitoring will most likely be centered on the study of blood glucose excursions.

Diabetes Conferences | Upcoming Diabetes Conferences | Obesity Summit | Endocrinology Conferences | Metabolism Events | Diabetes Meetings | Neuroendocrinology | Gestational Diabetes | Genetic of Obesity | Paediatric Endocrinology | Thyroid Disorders | Diabetes and Cancer

Track 9: Diabetes and Cardiology

Diabetes is a cardio metabolic disease that is characterized by inflammation. It raises practically every cardiovascular risk factor, and the majority of diabetics die from cardiac disease. However, recent clinical research findings combined with patient education provide new ways to enhance cardiovascular outcomes in diabetic patients. Diabetes and cardiovascular disease (CVD) have a complicated and multiple pathogenesis. Understanding these complex disease mechanisms can aid doctors in detecting and treating CVD in diabetic patients, as well as assisting patients in avoiding these potentially fatal consequences.

Diabetes Conferences | Upcoming Diabetes Conferences | Obesity Summit | Endocrinology Conferences | Metabolism Events | Diabetes Meetings | Neuroendocrinology | Gestational Diabetes | Genetic of Obesity | Paediatric Endocrinology | Thyroid Disorders | Diabetes and Cancer

Thailand Diabetes Care Devices Market is expected to register a CAGR greater than 7% over the forecast period, 2022 - 2027. The healthcare system was significantly disturbed and pressured during each phase of rapid COVID-19 infection. Several countries, notably the Thai government, have introduced home isolation or a home quarantine program to avert healthcare collapse and to ameliorate inadequate healthcare resources. Between July 2021 and October 2021, COVID-19 illness cases in Thailand increased to around 20,000-25,000 cases per day, posing difficulty in the treatment of COVID-19 infection in hospitals. Previous research revealed the viability of a COVID-19 home monitoring program employing telemedicine to reduce the gap in treatment during a healthcare worker shortage in multiple countries2-5. These programs primarily monitored the intensity of symptoms and informed patients to seek additional treatment if necessary. During COVID-19, there was a shortage of hospital capacity, and a home isolation system was set up. Thailand’s government introduced diabetes self-management education and support (DSMES) and glycemic management via telemedicine, along with outcomes in home-isolated patients with COVID-19 infection. In AUG 2022, The National Research Council of Thailand (NRCT) introduced a breathalyzer prototype that can detect those infected with Covid-19 with 97% accuracy.

Thailand’s government During COVID-19 provided medical supplies, including glucometers, blood glucose test strips, lancets, and urine test strips were donated or purchased using donated funds. The supplies were stocked at a central location and distributed by volunteers, utilizing same-day commercial delivery services. Disposable prefilled insulin pens, both long-acting and short-acting analogs, were chosen instead of insulin vials to reduce administration errors, particularly in insulin-naïve patients. Insulin pens were kept at a medical clinic and distributed in a temperature-controlled container by a same-day delivery service.

Scope of the Report

Thailand Diabetes Care Devices Market is expected to register a CAGR greater than 7% over the forecast period, 2022-2027. Thailand Diabetes Care Devices Market is segmented into Management Devices (Insulin Pumps, Insulin Pens, Syringes, Cartridges, and Jet Injectors) and Monitoring Devices (Self-monitoring Blood and Continuous Glucose Monitoring). Blood pressure regulation is a critical component of diabetes management. Furthermore, even in the absence of high blood pressure, certain blood pressure lowering medications are frequently recommended for people living with diabetes to protect them from kidney and heart-related complications. There is currently no scientific evidence linking these blood pressure drugs to the likelihood of COVID-19 infection or associated consequences.

Insulin therapy is the most potent hypoglycaemic medication currently available for diabetes treatment; however, the potency of insulin deteriorates if it is stored under improper conditions. In Thailand, NCDs including diabetes accounts for more than 70% of all deaths. Obesity leads to a more than seven times increase in the risk of developing type 2 diabetes while being overweight increases the risk by three times. Through Thailand’s government encouragement, the usage of Management Devices increased over the forecast period. Increasing Diabetes population in Thailand

The World Health Organization (WHO) estimates that in 2021, around 11% of the total health expenditure in Thailand is allocated to diabetes care, which is comparable to other countries in the region. By 2030, this figure is expected to grow by 41%, effectively doubling the societal burden of diabetes. In Thailand only 272 endocrinologists (or specialists) are available. In Thailand, three out of five people with diabetes who receive care do not achieve the recommended treatment targets. According to the WHO's report, the world's top five countries suffering from diabetes include Indonesia, China, India, Brazil, and the United States. Thailand is facing an increase in the number of diabetes patients due to the changing lifestyles, which is resulting in the prevalence of obesity. Sedentary lifestyles and unhealthy diets are more common in urban areas of Thailand. The Thai government is attempting to address the threat of diabetes mellitus through programs, like ‘Thailand Healthy Lifestyle Strategic Plan 2011-2020’. Such programs will help diabetic patients understand the benefits of various diabetes devices available in the market. The increasing diabetes population and the technological advancements in Indonesia are driving the market.

The creation of a world-class healthcare sector is a top priority for the Thailand and the healthcare sector is expected to advance and expand significantly in the next few years which will support the growth of Medical Device Market in the country. Aging population along with increase in number of hospitals and clinics, increase in total healthcare expenditure by the government and increase in medical tourism in the country are going to impact the demand for medical devices in the positive manner.

Thailand Medical Device Market Overview and Size:

Thailand recorded the 5.0% population growth rate over the last 7 years, with highest population concentrated in Bangkok. Majority of the healthcare facilities are concentrated in Bangkok and other central regions of the Thailand. The country has a comprehensive, government-funded health service and a rapidly developing private health sector, which is one of the major pillar of the industry. Universal Coverage Card is the most used insurance in Thailand. Social Security (SSS) is followed by Civil Servant Medical Benefit Scheme (CSMBS). Private insurance contributed 7.33% to the total insurances in Thailand. Diabetes and lung cancer causes most death in Indonesia.

Competitive Landscape in the Thailand Medical Devices Market:

The competition scenario in Thailand medical devices market is highly concentrated for Orthopedic Product and Diagnostics imaging market and moderately concentrated due to the presence of large number of international companies and local distributors leading to dilution of market share. The international companies distribute their products through authorized distributors located across the country. GE, Siemens, Philips, Canon and Fujifilm are the major companies operating in the Thailand Medical Device market. Meditop, Mind medical and R.X. Company are few top distributors in Thailand. The major competitive parameters include product portfolio, price, and after sales and warranty and technology

The Thailand medical device market is expected to grow at a double digit CAGR from 2021-2026F, with imports contributing majority of the market revenues. The creation of a world-class healthcare sector is a top priority for the Thailand and the healthcare sector is expected to advance and expand significantly in the next few years which will support the growth of Medical Device Market in the country. Aging population along with increase in number of hospitals and clinics, increase in total healthcare expenditure by the government and increase in medical tourism in the country are going to impact the demand for medical devices in the positive manner.

Thailand Medical Device Market Overview and Size:

Thailand recorded the 5.0% population growth rate over the last 7 years, with highest population concentrated in Bangkok. Majority of the healthcare facilities are concentrated in Bangkok and other central regions of the Thailand. The country has a comprehensive, government-funded health service and a rapidly developing private health sector, which is one of the major pillar of the industry. Universal Coverage Card is the most used insurance in Thailand. Social Security (SSS) is followed by Civil Servant Medical Benefit Scheme (CSMBS). Private insurance contributed 7.33% to the total insurances in Thailand. Diabetes and lung cancer causes most death in Indonesia.

International Endocrinology Congress -2020

Conference Series successfully hosted its premiere International Endocrinology Congress scheduled to be held during October 14-15, 2020 at Rome, Italy.  The conference was organized with a focus on “New Innovations, guidance and experimental approaches in endocrinal disorders” and it was a great success where eminent keynote speakers from various reputed organizations made their resplendent presence and addressed the gathering. Endocrinology Congress 2020 was marked by the attendance of Editorial Board Members of main Journals is the Journal of Endocrinology. Many Scientists, young and brilliant Researchers, Business Delegates and Talented Student Communities representing from varies countries made this conference fruitful and productive driving the two-day event into the path of success with thought-provoking keynote and plenary presentations.

Euro Diabetes Congress & Expo -2019

The Euro Diabetes Congress & Expo hosted by Conference Series took place online during September 20-21, 2019 at Prague, Czech Republic. It was organized by Conference Series and generous response was received from the Editorial Board Members of Conference Series Journals as well as from eminent scientists, talented researchers and young student community. Researchers and students who attended from different parts of the world made the conference one of the most successful and productive events in 2020 from Conference Series. The two days program witnessed thought provoking keynote and plenary presentations from experts in the field of  Diabetes, highlighting the theme “Diabetes: A view through the scope”

2nd Global Experts Meeting on Diabetes, Hypertension and Metabolic Syndrome -2018

Conference Series successfully hosted “2nd Global Experts Meeting on Diabetes, Hypertension and Metabolic Syndrome" scheduled through May 17-18, 2018 in Singapore with a theme, “Novel Innovations and Management in Diabetes Management”. It was organized by Conference Series and generous response was received from the Editorial Board Members of Conference Series Journals as well as from eminent scientists, talented researchers and young student community. Researchers and students who attended from different parts of the world made the conference one of the most successful and productive events in 2018 from Conference Series.

Global Experts Meeting on Diabetes, Hypertension, and Metabolic Syndrome -2018

With the successful completion of Conference "Global Experts Meeting on Diabetes, Hypertension, and Metabolic Syndrome" scheduled during July 30-31, 2018 in Melbourne, Australia with a theme, “Investigating the Challenges in Diabetes, Hypertension & Metabolic syndrome”. It was organized by Conference Series and generous response was received from the Editorial Board Members of Conference Series Journals as well as from eminent scientists, talented researchers and young student community. Researchers and students who attended from different parts of the world made the conference one of the most successful and productive events in 2018 from Conference Series. The two days program witnessed thought provoking keynote and plenary presentations from experts in the field of Diabetes.

International Conference on Diabetes and Diabetic Nursing Care -2017

Conference Series successfully hosted the International Conference on Diabetes and Diabetic Nursing Care during September 20-21, 2017 at Charlotte, North Carolina, USA. The conference focused on the theme “A Global Platform to reunite and Raise Hands against Diabetes”. The conference was successful in gathering eminent speakers from various reputed organizations and their paramount talks enlightened the gathering. The pragmatic meet organized by Conference Series received generous response from the Editorial Board Members of OMICS Group Journals as well as expertise from academia, talented researchers and young student community. Researchers and students who attended from different parts of the world made the conference one of the most successful events in 2017 from Conference Series Group. The conference was marked with the presence of renowned Speakers, Young researchers, students and business delegates driving the two day event into the path of success with thought provoking keynote and plenary presentations.

With the valuable feedback received from the participants of Diabetes 2022, Conference Series will be glad to announce its next event i.e. 3rd Annual Summit on Diabetes and Endocrinology scheduled for September 14-15, 2023 at Bangkok, Thailand